Results 241 to 250 of about 9,718,735 (366)

The occurrence of 19‐hydroxy F prostaglandins in human semen [PDF]

FEBS Letters, 1975
R.W. Kelly, P.L. Taylor
openaire   +3 more sources

Furosemide‐hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline

ESC Heart Failure, EarlyView.
Massimo Mapelli, Filippo Maria Rubbo, Jeness Campodonico, Nicola Cosentino, Giancarlo Marenzi, Valentina Mantegazza, Filippo Trombara, Mateusz Sokolski, Piotr Ponikowski, Piergiuseppe Agostoni   +9 more
wiley   +1 more source

Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts

International Journal of Cancer, EarlyView.
What's New? Exposures and mechanisms that contribute to and promote pancreatic ductal adenocarcinoma (PDAC) remain unclear. In this study, the authors applied metabolomics to better understand PDAC etiology by examining associations between prediagnostic serum metabolites and PDAC risk.
Ting Zhang, Steven C. Moore, Sheng Fu, Xiaoyu Wang, Demetrius Albanes, Stephanie J. Weinstein, Kai Yu, Rachael Z. Stolzenberg‐Solomon   +7 more
wiley   +1 more source

Tandem Administration of Prostaglandin F_2α and Gonadotropin-Releasing Hormone in Beef Heifers and Cows as a Convergent Presynchronization Method in the 7 & 7 Synch Protocol. [PDF]

Animals (Basel)
Palcheff LJ, VanWye GM, Ricardo KR, Green KL, Even FJ, Roberts SR, Lonas AB, Spinka CM, Poock SE, Menegatti Zoca S, Drum JN, Thomas JM.   +11 more
europepmc   +1 more source

Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population

International Journal of Cancer, EarlyView.
What's new? In recent years, the possible prognostic impact of concomitant medications in patients with cancer treated with immunotherapy combinations has generated increasing interest. This real‐world analysis evaluated the impact of concomitant medications on survival outcomes in patients with advanced biliary tract cancer treated with cisplatin ...
Federica Lo Prinzi, Francesca Salani, Silvia Camera, Mario Domenico Rizzato, Anna Saborowski, Lorenzo Antonuzzo, Federico Rossari, Tomoyuki Satake, Frederik Peeters, Tiziana Pressiani, Jessica Lucchetti, Jin Won Kim, Oluseyi Abidoye, Ilario Giovanni Rapposelli, Chiara Gallio, Stefano Tamberi, Fabian Finkelmeier, Guido Giordano, Pircher Chiara, Hong Jae Chon, Chiara Braconi, Aitzaz Qaisar, Alessandro Pastorino, Florian Castet, Emiliano Tamburini, Changhoon Yoo, Alessandro Parisi, Anna Diana, Mario Scartozzi, Gerald W. Prager, Antonio Avallone, Marta Schirripa, Il Hwan Kim, Lukas Perkhofer, Ester Oneda, Monica Verrico, Nuno Couto, Jorge Adeva, Stephen L. Chan, Gian Paolo Spinelli, Nicola Personeni, Ingrid Garajova, Maria Grazia Rodriquenz, Silvana Leo, Cecilia Melo Alvim, Ricardo Roque, Mariam Grazia Polito, Emanuela Di Giacomo, Giovanni Farinea, Linda Bartalini, Giada Grelli, Antonio De Rosa, Daniele Lavacchi, Masafumi Ikeda, Jeroen Dekervel, Monica Niger, Rita Balsano, Giuseppe Tonini, Minsu Kang, Giulia Tesini, Alessandra Boccaccino, Vera Himmelsbach, Matteo Landriscina, Selma Ahcene Djaballah, Tanios Bekaii‐Saab, Lorenzo Fornaro, Gianluca Masi, Arndt Vogel, Sara Lonardi, Margherita Rimini, Lorenza Rimassa, Andrea Casadei‐Gardini   +71 more
wiley   +1 more source

Prostaglandin dose and time to fetal expulsion after intrauterine fetal death at 22 to 28 gestational weeks in Sweden: A retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Prostaglandin regimens for induction of intrauterine fetal death (IUFD) <28 gestational weeks (GW) are unstandardized. We aimed to describe prostaglandin regimens for induction after IUFD and assess association between dose and time to fetal expulsion.
Fanny Berger, Eva Wiberg Itzel, Irene Sterpu, Margit Endler   +3 more
wiley   +1 more source

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

iMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu, Yu An, Yage Du, Zhaoming Cao, Jie Zheng, Jingya Wang, Tingyi Li, Xingen Lei, Yanhui Lu   +8 more
wiley   +1 more source

Role of prostaglandin F-2 and oxytocin in the regression of GnRH-induced abnormal corpora lutea in anoestrous ewes [PDF]

, 1989
M. G. Hunter, V. J. Ayad, Colin Gilbert, J. A. Southee, D.C. Wathes   +4 more
openalex   +1 more source

Induced parturition in swine with prostaglandin F<SUB>2α</SUB>.

, 1976
Shichiro Sugawara, Kazuyoshi Hashizume, Kiyoshi Totsukawa, Motoaki UMEZU, Junji MASAKI, Hiroshi Satō, Wakeo ABE, Minoru Watanabe, Noboru USAMI, Katsunobu SATO, Takenori Yoshida   +10 more
openalex   +2 more sources

Prostaglandin F-2 receptors in corpora lutea of pregnant rats and relationship with induction of 20 -hydroxysteroid dehydrogenase [PDF]

, 1989
Leonardo E. Bussmann
openalex   +1 more source